20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Scientific Significance of Vandetanib (CAS 443913-73-3) in Targeted Drug Development

At NINGBO INNO PHARMCHEM CO.,LTD., we are committed to supplying the scientific community with crucial research compounds. Vandetanib, identified by its CAS number 443913-73-3, is a molecule of significant scientific interest, particularly within the realm of targeted drug development. Its intricate interactions with key cellular signalling pathways make it an invaluable asset for researchers pushing the boundaries of medicine. The depth of Vandetanib research highlights its importance.

Vandetanib is a potent inhibitor of specific tyrosine kinases, including RET, VEGFR, and EGFR. These kinases are often implicated in the uncontrolled growth and survival of cancer cells. The study of Vandetanib kinase inhibitor applications provides critical insights into how blocking these pathways can lead to therapeutic benefits. By interfering with these molecular mechanisms, Vandetanib offers a targeted approach to combatting diseases where these kinases are overactive.

Understanding the Vandetanib mechanism of action is paramount for leveraging its full potential. It operates by downregulating the signalling cascades that promote tumor proliferation and angiogenesis. This targeted inhibition has led to its approval for specific cancer types, notably medullary thyroid cancer. The success of Vandetanib for medullary thyroid cancer is a significant milestone and fuels ongoing research into its utility for other malignancies.

The consistent Vandetanib chemical properties, such as its appearance as a white crystalline powder and high purity, ensure its reliability in scientific investigations. These properties are essential for researchers building comprehensive drug discovery chemical libraries, where compound integrity is critical for valid experimental outcomes. NINGBO INNO PHARMCHEM CO.,LTD. ensures that researchers have access to this vital compound with the highest standards of quality.

The scientific community's continued exploration of Vandetanib is vital for developing next-generation targeted therapies. Its role in inhibiting key oncogenic pathways solidifies its importance in drug development and underscores our commitment at NINGBO INNO PHARMCHEM CO.,LTD. to providing the tools that drive medical innovation forward.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Vandetanib (443913-73-3): A Key Compound in Pharmaceutical Oncology Research

Next: Vandetanib (443913-73-3): Advancing Cancer Treatment Through Kinase Inhibition

All Rights Reserved